Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Generation Bio Co - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
GBIO
Nasdaq
8731
https://generationbio.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Generation Bio Co
Generation Bio Announces the Acceptance of Five Abstracts and an Invited Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting
- Apr 22nd, 2024 9:31 pm
Generation Bio to Present at the 23rd Annual Needham Virtual Healthcare Conference
- Apr 2nd, 2024 10:59 am
Generation Bio Co Reports Full Year and Q4 2023 Financial Outcomes
- Mar 8th, 2024 9:32 am
Generation Bio Co. (GBIO) Reports Q4 Loss, Lags Revenue Estimates
- Mar 6th, 2024 10:40 pm
Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2023 Financial Results
- Mar 6th, 2024 9:20 pm
Generation Bio to Present at the 2024 TD Cowen Health Care Conference
- Feb 27th, 2024 11:59 am
Generation Bio (NASDAQ:GBIO) Is In A Good Position To Deliver On Growth Plans
- Feb 25th, 2024 12:13 pm
Generation Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference
- Jan 3rd, 2024 9:05 pm
Charles Rowland Bought 179% More Shares In Generation Bio
- Dec 7th, 2023 10:11 am
Director Rowland Charles A Jr Acquires 342,960 Shares of Generation Bio Co (GBIO)
- Dec 6th, 2023 8:05 am
Generation Bio Announces Strategic Reorganization to Extend Cash Runway for Development of ctLNP and iqDNA Platforms
- Nov 29th, 2023 11:59 am
Generation Bio Reports Business Highlights and Third Quarter 2023 Financial Results
- Nov 9th, 2023 9:15 pm
Generation Bio Announces Demonstration of Highly Selective T Cell Transduction In Vivo with Cell-Targeted LNP Platform
- Oct 26th, 2023 10:59 am
Generation Bio Announces Breakthrough in its Non-Viral Genetic Medicine Platform with Novel “Immune-Quiet” DNA
- Oct 18th, 2023 10:59 am
Generation Bio to Present at the Jefferies Cell & Genetic Medicine Summit
- Sep 19th, 2023 11:30 am
We're Not Worried About Generation Bio's (NASDAQ:GBIO) Cash Burn
- Sep 18th, 2023 10:13 am
Insider Buyers Lose US$80k As Generation Bio Sheds US$37m
- Aug 3rd, 2023 12:49 pm
Generation Bio to Present at the Canaccord Genuity 43rd Annual Growth Conference
- Aug 3rd, 2023 11:30 am
Generation Bio Co. (GBIO) Reports Q2 Loss, Misses Revenue Estimates
- Aug 2nd, 2023 11:05 pm
Generation Bio Reports Second Quarter 2023 Financial Results
- Aug 2nd, 2023 8:15 pm
Scroll